In prostate cancer, elevated TRPV6 expression was found to be regulated through a Ca/nuclear factor of activated T-cell transcription factor (NFAT) or an Orai1/Annexin/S100A11 pathway33,34 but how the expression is upregulated in breast cancer is poorly understood10. Here, ORAI1 is linked to prostate carcinoma.